Erratum to: JAK–STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects

被引：0
|
作者：
Shubhasree Banerjee
Ann Biehl
Massimo Gadina
Sarfaraz Hasni
Daniella M. Schwartz
机构：
[1] National Institute of Arthritis Musculoskeletal and Skin Diseases,Rheumatology Fellowship and Training Branch
[2] National Institutes of Health,Clinical Center
[3] National Institutes of Health,Translational Immunology Section
[4] National Institute of Arthritis Musculoskeletal and Skin diseases,Lupus Clinical Research Program
[5] National Institutes of Health,Molecular Immunology and Inflammation Branch
[6] National Institute of Arthritis Musculoskeletal and Skin diseases,undefined
[7] National Institutes of Health,undefined
[8] National Institute of Arthritis Musculoskeletal and Skin diseases,undefined
[9] National Institutes of Health,undefined
来源：
Drugs | 2017年 / 77卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：939 / 939
相关论文
共 50 条
  • [1] Erratum to: JAK–STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects
    Shubhasree Banerjee
    Ann Biehl
    Massimo Gadina
    Sarfaraz Hasni
    Daniella M. Schwartz
    Drugs, 2017, 77 : 1261 - 1261
  • [2] JAK–STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects
    Shubhasree Banerjee
    Ann Biehl
    Massimo Gadina
    Sarfaraz Hasni
    Daniella M. Schwartz
    Drugs, 2017, 77 : 521 - 546
  • [3] JAK-STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects
    Banerjee, Shubhasree
    Biehl, Ann
    Gadina, Massimo
    Hasni, Sarfaraz
    Schwartz, Daniella M.
    DRUGS, 2017, 77 (05) : 521 - 546
  • [4] JAK-STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects (vol 77, pg 521, 2017)
    Banerjee, Shubhasree
    Biehl, Ann
    Gadina, Massimo
    Hasni, Sarfaraz
    Schwartz, Daniella M.
    DRUGS, 2017, 77 (08) : 939 - 939
  • [5] JAK-STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects (vol 77, pg 521, 2017)
    Banerjee, Shubhasree
    Biehl, Ann
    Gadina, Massimo
    Hasni, Sarfaraz
    Schwartz, Daniella M.
    DRUGS, 2017, 77 (11) : 1261 - 1261
  • [6] Targeting JAK/STAT Signaling Pathway in Inflammatory Diseases
    Malemud, Charles Jay
    Pearlman, Eric
    CURRENT SIGNAL TRANSDUCTION THERAPY, 2009, 4 (03) : 201 - 221
  • [7] Defective JAK-STAT Pathway Signaling Contributes to Autoimmune Diseases
    Malemud C.J.
    Current Pharmacology Reports, 2018, 4 (5) : 358 - 366
  • [8] JAK/STAT signaling in renal diseases
    Chuang, Peter Y.
    He, John C.
    KIDNEY INTERNATIONAL, 2010, 78 (03) : 231 - 234
  • [9] JAK/Stat signaling in cardiac diseases
    Siddiqui, MAQ
    Mascareno, E
    SIGNAL TRANSDUCTION AND CARDIAC HYPERTROPHY, 2003, 7 : 349 - 356
  • [10] Efferocytosis: Current status and future prospects in the treatment of autoimmune diseases
    Li, Qianwei
    Liu, Huan
    Yin, Geng
    Xie, Qibing
    HELIYON, 2024, 10 (07)
12345